# The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

> **NCT07298915** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Virginia** · enrollment: 24 (estimated)

## Conditions studied

- Obesity & Overweight

## Interventions

- **DRUG:** Tirzepatide
- **BEHAVIORAL:** Exercise

## Key facts

- **NCT ID:** NCT07298915
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07298915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07298915, "The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07298915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*